Inici › Càncer de pròstata › Ohio › Columbus
Assaigs clínics de Càncer de pròstata a Columbus, OH
24 estudis de Càncer de pròstata busquen participants en centres de Columbus i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- i 8 més
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- i 11 més
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ReclutantFase 2/3
- Central Ohio Urology Group, Gahanna · a 7 mi
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ReclutantFase 3
- The Ohio State University, Columbus
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutantFase 3
- Central Ohio Urology Group, Gahanna · a 7 mi
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
ReclutantFase 3
- Research Site, Columbus
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ReclutantFase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- i 4 més
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
ReclutantFase 1/2
- The Ohio State University, Columbus
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
ReclutantFase 1
- The Ohio State University, Columbus
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
ReclutantFase 1
- The Ohio State University, Columbus
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutantFase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
ReclutantFase 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutantFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
ReclutantFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Columbus
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
ReclutantFase 2
- Central Ohio Urology Group, Gahanna · a 7 mi
Assaigs de Càncer de pròstata en altres ciutats
- New York City, NY103 estudis
- Houston, TX76 estudis
- Los Angeles, CA61 estudis
- Boston, MA59 estudis
- St. Louis, MO46 estudis
- Chicago, IL45 estudis
- San Francisco, CA45 estudis
- Philadelphia, PA44 estudis
- Baltimore, MD43 estudis
- Nashville, TN42 estudis
- Seattle, WA42 estudis
- Washington, DC38 estudis
Altres estudis a Columbus
- Càncer de pulmó de cèl·lules no petites56 estudis
- Càncer de mama39 estudis
- Càncer d'ovari39 estudis
- Càncer (tots els tipus)38 estudis
- Càncer de pulmó37 estudis
- Leucèmia mieloide aguda35 estudis
- Leucèmia limfàtica crònica28 estudis
- Càncer metastàtic27 estudis
- Càncer d'endometri25 estudis
- Càncer colorrectal24 estudis
- Mieloma múltiple24 estudis
- Melanoma21 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.